Dr. Malikova graduated from the Institute of Biochemistry, Russian Academy of Science, in Moscow, Russia with a PhD in Biochemistry. She has a strong background in biomedical sciences and has completed her postdoctoral fellowship in the field of cell signaling and cell migration. She also holds a Master’s Degree in Clinical Investigation and Project Management Certification from Boston University.
In her current role as Executive Director, Dr. Malikova manages research efforts in seven divisions of the Department of Surgery at Boston Medical Center. She is responsible for clinical trials and basic biomedical research operations, risk management, strategic planning, and macro-management of research programs. She provides guidance and oversight to the Project Managers, Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and laboratory staff. She also provides assistance to investigators with protocol and informed consent writing, regulatory submissions, clinical trial agreements and budget development.
Boston University School of Medicine
Surgical Translational Research Operations and Compliance
2015 BU BEST Mentoring Circle:
Valued Mentor Award
2001 International Union of Biochemistry and Molecular Biology:
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 14 results.
Malikova MA. Practical applications of regulatory requirements for signal detection and communications in pharmacovigilance. Ther Adv Drug Saf. 2020; 11:2042098620909614. PMID: 32313617; PMCID: PMC7160767; DOI: 10.1177/2042098620909614;
Kaliaev AO, Malikova MA. Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment. Ther Innov Regul Sci. 2020 07; 54(4):803-813. PMID: 32557305
Malikova MA, Tkacz JN, Slanetz PJ, Guo CY, Aakil A, Jara H. Evaluation of T1/T2 ratios in a pilot study as a potential biomarker of biopsy: proven benign and malignant breast lesions in correlation with histopathological disease stage. Future Sci OA. 2017 Aug; 3(3):FSO197.View Related Profiles. PMID: 28883997; PMCID: PMC5583698; DOI: 10.4155/fsoa-2016-0063;
Malikova MA. Optimization of protocol design: a path to efficient, lower cost clinical trial execution. Future Sci OA. 2016 Mar; 2(1):FSO89. PMID: 28031939; PMCID: PMC5137936; DOI: 10.4155/fso.15.89;
Eslami MH, Doros G, Goodney PP, Elderup-Jorgenson J, Cronenwett JL, Malikova M, Farber A. Using vascular quality initiative as a platform for organizing multicenter, prospective, randomized clinical trials: OVERPAR trial. Ann Vasc Surg. 2015 Feb; 29(2):278-85.View Related Profiles. PMID: 25311746; PMCID: PMC4314323; DOI: 10.1016/j.avsg.2014.08.007;
Farber A, Belenky A, Malikova M, Brenner O, Brandeis Z, Migdal M, Orron D, Kim D. The evaluation of a novel technique to treat saphenous vein incompetence: preclinical animal study to examine safety and efficacy of a new vein occlusion device. Phlebology. 2014 Feb; 29(1):16-24.View Related Profiles. PMID: 23202139; DOI: 10.1258/phleb.2012.012003;
Malikova MA, Doros G, Joglar F, Rybin D, Petros JG, Farber A. A third-year surgery clerkship with extensive exposure to vascular surgery improves knowledge about vascular disease and the role of vascular surgeons in its management. Vasc Endovascular Surg. 2010 Jul; 44(5):361-7.View Related Profiles. PMID: 20484079; DOI: 10.1177/1538574410362111;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.